Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Announcing Ground-Breaking Technology for Anti-Aging, FDA Approved, Venus Viva.
  • USA - English


News provided by

Lakes Dermatology

May 30, 2015, 03:00 ET

Share this article

Share toX

Share this article

Share toX

The latest in anti-aging skincare - Venus Viva
The latest in anti-aging skincare - Venus Viva

I was very pleased to be part of the testing of Venus Viva as it earned full FDA approval.

Post this

Las Vegas, Nevada (PRWEB) May 30, 2015 -- Venus Viva has proven to work in the effective treatment of acne scars, large pores, deep wrinkles, stretch marks, pigmentation irregularities, and uneven texture when used by a licensed medical professional, such as Dr. F. Victor Rueckl of Lakes Dermatology in Las Vegas who conducted some of the clinical trials in Las Vegas. This body image solution combines NanoFractional Radio Frequency (RF) and SmartScan technology into a system that delivers proven results through a skin heating process that offers minimal discomfort to the patient. Venus Viva devices feature 160 pins per tip with 62mj per pin, as well as a smaller footprint per pin (150x20 Microns), that results in a minimal downtime for the patient undergoing the procedure. (2)

It's a never-ending struggle for people to maintain a healthy and youthful appearance as they get older. Nature can be quite unkind as one ages, with skin starting to sag and lines and wrinkles marching across one's face. Then there's the issue of common skin ailments such as acne and rosacea that inflict millions of people of every age. Now dermatologists have another tool at their disposal in this fight to turn back the ravages of time as the FDA has recently approved the use of Venus Viva as an effective and safe treatment for facial remodeling and resurfacing. In fact, nonsurgical skin tightening procedures have become increasingly popular over the last few years. In 2014 alone, there were 283,259 women and 14,964 men who underwent such procedures to enhance their appearance. (1)

Another important feature of Venus Viva is that it is skin color blind, meaning that it can be safely and effectively used for all skin types. There is minimal downtime to using this FDA-approved product as treatment to one area can be done in as little as fifteen to thirty minutes, thus allowing the patient to get on with their day. Patients can start seeing younger and clearer skin in as few as three treatments, although the manufacturer suggests a full course of six treatments for the face and anywhere from eight to ten treatments on the body to obtain optimal results. As always, such procedures should always be carried out by a licensed dermatologist, such as Dr. F. Victor Rueckl of Lakes Dermatology, as that while the procedure is non-invasive, there is always the risk of complications.

Venus Viva is both portable and easy to use to help achieve a youthful, healthy skin tone. Dr. F. Victor Rueckl of Lakes Dermatology in Las Vegas conducted the FDA trial for Venus Viva, and he notes, "I was very pleased to be part of the testing of Venus Viva as it earned full FDA approval. This product is another useful tool that my office can use to help our clientele turn back the clock by improving skin appearance by tightening the skin and reducing the appearance of common problems such as acne scarring and rosacea. Venus Viva is for dermatological procedures requiring ablation and resurfacing of the skin, but it is much less ablative or dangerous than CO2. It could also have other possible uses in the future, such as the treatment of melasma, a common skin problem that affects women more than men. Our work has shown encouraging signs in the use of Venus Viva to reduce and minimize the effects of melasma. Since Venus Viva was recently approved by the FDA, very few dermatology offices currently have it in their inventory, but my office of Lakes Dermatology in Las Vegas has it, and we're quite experienced in using it to its fullest potential." (3)

The reality of life is that we age as we get older, but people now have options available to them to help turn back the tide of time and regain a youthful, healthy appearance. Venus Viva has shown that it is a safe and effective tool to be used to reduce wrinkles, tighten skin, reduce stretch marks and acne, and much more as it earned FDA approval. As is always the case when considering any cosmetic procedure, consult with an experienced medical professional, such as Dr. F. Victor Rueckl of Lakes Dermatology in Las Vegas, before undergoing any treatments. They can fully explain all the options available to the patient, any associated risks, and what results are most likely expected.

References:

1) http://www.smartbeautyguide.com/procedures/skin-hair/nonsurgical-skin-tightening

2) http://www.venusconcept.com/products/venus-viva/

3) Quote from Dr. F. Victor Rueckl, dermatologist at Lakes Dermatology

Katie Rueckl, Lakes Dermatology, http://www.lakesdermatology.com, +1 9703890932, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.